Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The exenatide group performed better on motor tests-which measured factors such as tremors, agility and speech-than did the placebo group, both at 48 weeks and at a 12-week follow-up
The goal remains evidence-informed care that prioritises patient safety and optimises outcomes
J.DavisC.DeVitaP
Dropout was higher in the 12 mg arm than in the 9 mg arm, reinforcing a pattern already visible in Phase 2: the marginal efficacy gain from pushing to 12 mg comes at real tolerability cost
US$ 24.73
US$ 25.66
US$ 20.79
US$ 24.83
US$ 29.49
US$ 26.02
